Luther King Capital Management Corporation »

Halozyme Therapeutics shares owned by Luther King Capital Management Corporation

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Luther King Capital Management Corporation from 13F filings

Historical chart of Luther King Capital Management Corporation investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Luther King Capital Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Luther King Capital Management Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.9M 66k 73.34
2025-06-30 $3.4M 66k 52.02
2025-03-31 $4.2M 66k 63.81